DK1887888T3 - Anvendelse af polydextrose til simulering af de funktionelle egenskaber af humane mælkeoligosaccharider hos spædbørn med kunstig næring - Google Patents

Anvendelse af polydextrose til simulering af de funktionelle egenskaber af humane mælkeoligosaccharider hos spædbørn med kunstig næring

Info

Publication number
DK1887888T3
DK1887888T3 DK06739414.8T DK06739414T DK1887888T3 DK 1887888 T3 DK1887888 T3 DK 1887888T3 DK 06739414 T DK06739414 T DK 06739414T DK 1887888 T3 DK1887888 T3 DK 1887888T3
Authority
DK
Denmark
Prior art keywords
polydextrose
simulate
human milk
milk oligosaccharides
functional properties
Prior art date
Application number
DK06739414.8T
Other languages
English (en)
Other versions
DK1887888T4 (da
Inventor
Glenn R Gibson
Robert A Rastall
Renia Gemmell
Maria Saarela
Anna-Marja Aura
Bryon W Petschow
Robert J Mcmahon
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36602547&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1887888(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Application granted granted Critical
Publication of DK1887888T3 publication Critical patent/DK1887888T3/da
Publication of DK1887888T4 publication Critical patent/DK1887888T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK06739414.8T 2005-06-01 2006-03-23 Anvendelse af polydextrose og galactooligosaccharid til simulering af de funktionelle egenskaber for oligosaccharider i modermælk hos spædbørn, der får modermælkserstatning DK1887888T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68639005P 2005-06-01 2005-06-01
US11/172,123 US7572474B2 (en) 2005-06-01 2005-06-30 Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
PCT/US2006/010608 WO2006130205A1 (en) 2005-06-01 2006-03-23 Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants

Publications (2)

Publication Number Publication Date
DK1887888T3 true DK1887888T3 (da) 2011-01-17
DK1887888T4 DK1887888T4 (da) 2014-11-03

Family

ID=36602547

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06739414.8T DK1887888T4 (da) 2005-06-01 2006-03-23 Anvendelse af polydextrose og galactooligosaccharid til simulering af de funktionelle egenskaber for oligosaccharider i modermælk hos spædbørn, der får modermælkserstatning

Country Status (18)

Country Link
US (4) US7572474B2 (da)
EP (2) EP2374362A3 (da)
KR (1) KR101244097B1 (da)
CN (2) CN102657262B (da)
AT (1) ATE485728T1 (da)
BR (1) BRPI0611020B1 (da)
CA (3) CA2815780C (da)
DE (1) DE602006017830D1 (da)
DK (1) DK1887888T4 (da)
ES (1) ES2356196T5 (da)
MX (1) MX2007014977A (da)
MY (1) MY147771A (da)
NO (1) NO335319B1 (da)
PL (1) PL1887888T5 (da)
PT (1) PT1887888E (da)
RU (1) RU2415674C2 (da)
TW (1) TWI391100B (da)
WO (1) WO2006130205A1 (da)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8927253B2 (en) * 2007-02-01 2015-01-06 Master Supplements, Inc. Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy
US8568712B2 (en) * 2007-02-01 2013-10-29 Master Supplements, Inc. Enzyme and prebiotic combinations for enhancing probiotic efficacy
US8889119B2 (en) * 2007-02-01 2014-11-18 Master Supplements, Inc. Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy
US10251899B2 (en) * 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
IT1395068B1 (it) 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
US20110189342A1 (en) * 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
US20110293783A1 (en) * 2010-05-28 2011-12-01 Anja Wittke Nutritional compositions for enhancing immune function
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
EP2452571A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of complementary infant/young child nutritional compositions
US20120135103A1 (en) 2010-11-30 2012-05-31 Mead Johnson Nutrition Company Staged Infant Feeding Regimen To Promote Healthy Development And Growth
WO2012087113A1 (en) * 2010-12-24 2012-06-28 N.V. Nutricia Improved nutritional tablet
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
MX2013006094A (es) * 2010-12-29 2013-07-03 Mjn Us Holdings Llc Metodo para inhibir patogenos usando composicion nutricional.
US8648036B2 (en) 2010-12-29 2014-02-11 Mead Johnson Nutrition Company Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US20120171164A1 (en) * 2010-12-29 2012-07-05 Anja Wittke Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections
US20120172288A1 (en) * 2010-12-29 2012-07-05 Anja Wittke Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
US20120171163A1 (en) * 2010-12-29 2012-07-05 Anja Wittke Method for inhibiting a bacterial invasive mechanism using a nutritional composition
EP2658389A1 (en) 2010-12-29 2013-11-06 MJN U.S. Holdings LLC Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
US20120171231A1 (en) * 2010-12-29 2012-07-05 Anja Wittke Use of nutritional compositions including lactoferrin in stimulating immune cells
US20120171328A1 (en) 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
US20120269929A1 (en) 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
RU2468087C1 (ru) * 2011-08-09 2012-11-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Вятский государственный университет" Способ выявления жизнеспособных пробиотических микроорганизмов в условиях in vitro, имитирующих процесс пищеварения у человека
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US20130089638A1 (en) 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
ES2559381T3 (es) * 2011-10-18 2016-02-11 Nestec S.A. Composición para su uso en la promoción del crecimiento de hueso sano y/o en la prevención y/o tratamiento de osteopatía
WO2014099134A1 (en) * 2012-12-18 2014-06-26 Mjn U.S. Holdings Llc Milk-based nutritional compositions containing lactoferrin and uses thereof
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
CN103724446A (zh) * 2013-12-27 2014-04-16 光明乳业股份有限公司 一种鼠李糖乳杆菌的胞外多糖及其制备方法和应用
US20150290261A1 (en) * 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20160029682A1 (en) * 2014-08-01 2016-02-04 Mead Johnson Nutrition Company Hydrolyzed lactose-containing nutritional compositions and uses thereof
PL3065748T3 (pl) 2014-12-23 2018-07-31 4D Pharma Research Limited Szczep Bacteroides thetaiotaomicron i jego zastosowanie w zmniejszaniu zapalenia
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
US20160353774A1 (en) * 2015-06-02 2016-12-08 Mead Johnson Nutrition Company Nutritional compositions comprising spore-forming probiotics
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EA201890050A1 (ru) 2015-06-15 2018-06-29 4Д Фарма Рисёрч Лимитед Композиции, содержащие бактериальные штаммы
MD3650033T2 (ro) 2015-06-15 2022-08-31 4D Pharma Res Ltd Compoziții conţinând tulpini bacteriene
SI3240554T1 (sl) 2015-06-15 2019-12-31 4D Pharma Research Limited, Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni
US10617701B2 (en) * 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10034937B2 (en) * 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
AU2016357554B2 (en) 2015-11-20 2019-04-04 Cj Bioscience, Inc. Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
US11229659B2 (en) 2016-01-26 2022-01-25 Societe Des Produits Nestle S.A. Compositions with specific oligosaccharides to prevent or treat allergies
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
EP3520801A1 (en) 2016-03-04 2019-08-07 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
CA3021022C (en) * 2016-04-14 2024-04-23 ChromaDex Inc. Use of nicotinamide riboside, nicotinic acid riboside, nicotinamide mononucleotide, and nicotinoyl compound derivatives in infant formula
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
WO2018081441A1 (en) * 2016-10-26 2018-05-03 Nutech Ventures Use of probiotic bacterial strains and cell extracts to inhibit acidosis and liver abscesses in cattle
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
JP7212945B2 (ja) 2017-05-22 2023-01-26 フォーディー ファーマ リサーチ リミテッド 細菌株を含む組成物
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
CN115813955A (zh) 2017-06-14 2023-03-21 4D制药研究有限公司 包含细菌菌株的组合物
MD3804737T2 (ro) 2017-06-14 2022-10-31 4D Pharma Res Limited Compoziții care conțin tulpini bacteriene
WO2018229188A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN108902325A (zh) * 2018-09-06 2018-11-30 东北农业大学 一种具有益生功能的婴幼儿配方奶粉复合包及其制备方法
NL2021737B1 (en) * 2018-10-01 2020-05-07 Nutricia Nv Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
CN115024361A (zh) * 2021-03-03 2022-09-09 内蒙古伊利实业集团股份有限公司 一种改善骨健康的配方牛奶及制备方法和应用
CN113966845A (zh) * 2021-10-22 2022-01-25 内蒙古蒙牛乳业（集团）股份有限公司 一种促进婴儿肠道健康的营养组合
CN119546755A (zh) 2022-07-15 2025-02-28 帝斯曼知识产权资产管理有限公司 用于体内合成复杂岩藻糖基化人乳寡糖的新型岩藻糖基转移酶
DK181765B1 (en) 2022-07-15 2024-12-04 Dsm Ip Assets Bv Cells expressing new fucosyltransferases for in vivo synthesis of lnfp-iii, and methods and uses of same
DK181911B1 (en) 2022-07-15 2025-03-18 Dsm Ip Assets Bv GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING A FUCOSYLTRANSFERASE FOR IN VIVO SYNTHESIS OF COMPLEX FUCOSYLATED HUMAN MILK OLIGOSACCHARIDES (HMOs) AND METHODS FOR PRODUCING THE HMOs AND USE OF THE ENZYME
WO2024042235A1 (en) 2022-08-25 2024-02-29 Dsm Ip Assets B.V. Hybrid method for producing complex hmos
CN120265786A (zh) 2022-11-25 2025-07-04 帝斯曼知识产权资产管理有限公司 用于生产寡糖的双菌株系统
DK182292B1 (en) 2022-12-22 2026-02-24 Dsm Ip Assets Bv Genetically engineered cells comprising new fucosyltransferases for in vivo synthesis of complex fucosylated human milk oligosaccharides mixtures comprising lndfh-iii and methods, uses, and mixtures produced using the same
DK182227B1 (en) 2023-10-17 2025-12-18 Dsm Ip Assets Bv Genetically engineered cells comprising new fucosyltransferases for in vivo synthesis of complex fucosylated human milk oligosaccharides mixtures comprising lnfp-vi, methods using the same, and uses of new fucosyltransferases thereof.

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115645A (ja) * 1984-07-03 1986-01-23 Meiji Milk Prod Co Ltd カルシウム強化飲料及びその製造法
CA1324529C (en) 1987-09-15 1993-11-23 Tatsuhiko Kan Liquid food comprising polydextrose and oligosaccharides
US4906482A (en) * 1986-03-19 1990-03-06 Zemel Michael B Method of making calcium fortified soy milk and the calcium fortified soy milk
GB8723094D0 (en) 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
CA1333471C (en) 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
CA1338682C (en) 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
US5795611A (en) * 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DE69133442T2 (de) * 1990-07-13 2006-01-12 Gropep Ltd., Thebarton Wachstumsfördernder wirkstoff
US6319522B1 (en) * 1990-07-13 2001-11-20 Gropep Limited Growth-promoting agent
ES2157898T3 (es) 1991-01-24 2001-09-01 Martek Corp Aceites microbianos y usos de los mismos.
EP0527283B1 (en) 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Food composition
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
JP2654529B2 (ja) 1992-03-27 1997-09-17 大塚製薬株式会社 健康飲料組成物
US5397589A (en) * 1992-09-02 1995-03-14 Ohio State University Research Foundation Preparation of calcium fortified powdered milk products with improved dispersibility
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
JP2893953B2 (ja) * 1992-10-27 1999-05-24 藤沢薬品工業株式会社 ビフィドバクテリウム菌の増殖促進剤
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
AUPM534794A0 (en) * 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
RU2142711C1 (ru) * 1996-01-18 1999-12-20 Лотте Ко., Лтд. Безлактозное молоко (варианты), пищевой продукт (варианты) и способы их получения
US6428832B2 (en) * 1996-03-26 2002-08-06 Dsm N.V. Late addition of PUFA in infant formula preparation process
EP0852913A1 (en) 1997-01-14 1998-07-15 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
CA2223198A1 (en) * 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US5840361A (en) 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
ES2168785T5 (es) 1997-07-05 2009-04-16 Societe Des Produits Nestle S.A. Absorcion de minerales por las celulas intestinales.
US6841149B1 (en) 1998-05-29 2005-01-11 Agri-King, Inc. Probiotic mixture intended for monogastric animals to control intestinal flora populations
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6866877B2 (en) * 1998-12-29 2005-03-15 Mac Farms, Inc. Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
US6706287B2 (en) 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
AU6232899A (en) 1999-10-06 2001-05-10 Campina Melkunie B.V. Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
DE69925870T2 (de) 1999-10-06 2005-12-08 Campina B.V. Verfahren zur bereitstellung von wachstumsfaktozubereitungen (tgf-beta und igf-1) mit niedriger gegenseitiger verunreinigung aus milchprodukten
DE19958985A1 (de) 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
US6630452B2 (en) 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
EP1261355B1 (en) 2000-03-01 2004-12-01 Société des Produits Nestlé S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
RU2283665C2 (ru) 2000-12-22 2006-09-20 Сосьете Де Продюи Нестле С.А. Индуцирование толерантности
EP1355542B2 (en) 2000-12-27 2012-04-04 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (en) 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US20040102377A1 (en) * 2001-04-10 2004-05-27 Irene Perrin Method and composition for prophylaxis of diabetes
EP1389426A4 (en) * 2001-04-25 2005-01-12 Yakult Honsha Kk FERMENTED FOODS AND METHOD FOR THEIR PRODUCTION
FR2827290B1 (fr) * 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
FI20020078A7 (fi) 2002-01-15 2003-07-16 Danisco Immuunijärjestelmän stimulointi polydextroosilla
FI119429B (fi) † 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
EP1549151A1 (en) 2002-10-11 2005-07-06 Wyeth Nutritional formulations containing synbiotic substances
US7138151B2 (en) * 2002-11-22 2006-11-21 Unilab Pharmatech, Ltd. Calcium-fortified acidic beverages
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
US20040191295A1 (en) * 2003-03-28 2004-09-30 Locniskar Mary Frances Composition and method for viral inhibition
DE10328180A1 (de) * 2003-06-16 2005-01-13 Südzucker AG Mannheim/Ochsenfurt Verwendung von Isomalt als Präbiotikum
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
PT1638414E (pt) * 2003-06-23 2009-07-13 Nestec Sa Fórmula para lactentes ou fórmula de transição
NZ544642A (en) * 2003-06-23 2009-01-31 Nestec Sa Infant or follow-on formula
WO2005039318A1 (en) 2003-10-16 2005-05-06 Nestec S.A. Nutritional composition against side effects of chemotherapy of radiotherapy
ES2781848T3 (es) 2003-10-24 2020-09-08 Nutricia Nv Oligosacáridos inmunomoduladores
JP4740866B2 (ja) * 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物
US20050158425A1 (en) * 2003-12-04 2005-07-21 Purac Biochem Bv Thin mouthfeel calcium-fortified beverage containing calcium lactate gluconate citrate
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
WO2006132968A1 (en) * 2005-06-06 2006-12-14 Bristol-Myers Squibb Company Low-phytate infant formulas
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility

Also Published As

Publication number Publication date
BRPI0611020A2 (pt) 2010-08-10
US20090176734A1 (en) 2009-07-09
KR20080014811A (ko) 2008-02-14
PL1887888T3 (pl) 2011-07-29
NO20075543L (no) 2008-01-23
US20060286258A1 (en) 2006-12-21
NO335319B1 (no) 2014-11-10
US8557320B2 (en) 2013-10-15
EP2374362A2 (en) 2011-10-12
BRPI0611020B1 (pt) 2018-04-03
PT1887888E (pt) 2010-12-20
CN101188947B (zh) 2012-07-04
CA2991450C (en) 2019-09-03
HK1121645A1 (en) 2009-04-30
CA2815780C (en) 2018-02-13
RU2415674C2 (ru) 2011-04-10
MX2007014977A (es) 2008-02-15
US8021708B2 (en) 2011-09-20
CN102657262B (zh) 2014-07-23
US8277863B2 (en) 2012-10-02
US20120328585A1 (en) 2012-12-27
RU2007144333A (ru) 2009-07-20
EP1887888B2 (en) 2014-08-13
CA2610711C (en) 2013-07-30
TW200744478A (en) 2007-12-16
CA2815780A1 (en) 2006-12-07
ES2356196T3 (es) 2011-04-05
ATE485728T1 (de) 2010-11-15
DE602006017830D1 (de) 2010-12-09
KR101244097B1 (ko) 2013-03-19
EP2374362A3 (en) 2012-03-14
CN102657262A (zh) 2012-09-12
CA2610711A1 (en) 2006-12-07
PL1887888T5 (pl) 2015-02-27
MY147771A (en) 2013-01-31
EP1887888B1 (en) 2010-10-27
WO2006130205A1 (en) 2006-12-07
CA2991450A1 (en) 2006-12-07
DK1887888T4 (da) 2014-11-03
CN101188947A (zh) 2008-05-28
ES2356196T5 (es) 2014-11-03
EP1887888A1 (en) 2008-02-20
TWI391100B (zh) 2013-04-01
US7572474B2 (en) 2009-08-11
HK1175659A1 (en) 2013-07-12
US20090311379A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
DK1887888T4 (da) Anvendelse af polydextrose og galactooligosaccharid til simulering af de funktionelle egenskaber for oligosaccharider i modermælk hos spædbørn, der får modermælkserstatning
CY2018013I1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
EP1847977A4 (en) MODELING DEVICE FOR MEDICAL TRAINING
IL227934A (en) An immunogenic preparation containing polysaccharide or oligosaccharide from s. type 5 or 8 aureus and various aspects related to it
EP1954361A4 (en) REGULAR PLAYING OF PLAYS WITH SEVERAL FILE
BRPI0809818A2 (pt) "composição de alimento seco e composição de alimento seco vegetariano"
EP2097140A4 (en) POLYMER PACKAGING AND / OR BONDING
EA200900044A1 (ru) Замещенные производные 1,3-дифенилпропана, получение и их применение
EP2626077A3 (en) Compositions for promoting bone and joint health
EP1901690A4 (en) ABSORBENT ARTICLE OF LACE TYPE WITH ELASTIC WAISTBAND
EP2183355A4 (en) COMPOSITIONS AND METHODS FOR MODIFICATION OF PHYSIOLOGICAL RESPONSES IN PLANTS
WO2007118963A3 (fr) Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
FR2882054B1 (fr) Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
EP2000506A4 (en) FORMABILITY MODIFICATOR AND POLYPROPYLENE-RESIN COMPOSITION FOR THIS
ATE524159T1 (de) Zusammensetzung zur dauerhaften verformung des menschlichen haares
BRPI0418378A (pt) combinações de substáncias ativas com propriedades inseticidas
CY1112922T1 (el) Συνθεσεις που προοριζονται για την αυξηση της ορεξης των χοιριδιων
EP1914273A4 (en) ETHER COMPOSITION AND SOLUTION COMPOSITION
EP1907083A4 (en) RACE GAME AND PROCEDURE
FR2887548B1 (fr) Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique
EP2056826A4 (en) COMPOSITIONS AND METHODS FOR INCREASING THROMBOXYTIC MIRRORS IN HUMANS
UA12321S (uk) Штани дитячі
PT1954261T (pt) Utilização de fenofibrato ou de um seu derivado no tratamento de retinopatia diabética
EP1857816A4 (en) METHOD FOR SCREENING A THERAPEUTIC AGENT FOR DARMIRRITATION SYNDROME
ATE516012T1 (de) Zusammensetzung mit natürlichen capsicumextrakten